Project Grant HT9425261E317
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
- The U.S. Department of Defense's Defense Health Agency awarded a $319,204 Project Grant to the Icahn School of Medicine at Mount Sinai (ISMMS) to conduct research on "Advanced Brain Age Modeling in Multiple Sclerosis: Toward a Prognostic Biomarker for Personalized Medicine." The award, which runs from August 15, 2024, to August 14, 2026, is part of the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research initiatives aimed at...
- LIVEWELL Brain Health Study - Federal Grant Award Summary The Defense Health Agency awarded Icahn School of Medicine at Mount Sinai a $7.69M Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support the LIVEWELL (Living with Violence-Related Brain Injury: Optimizing Cognitive and Psychological Wellness) Brain Health Study from September 30, 2025 through September 29, 2029. This four-year initiative delivers comprehensive research and development...
- Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a Project Grant of $745,195 under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2026, through August 31, 2029. The project, titled "Accelerating Personalized TCR Immunotherapy for Microsatellite-Stable Colorectal Cancer with a Multimodal Prediction Model," will develop advanced immunotherapy approaches and predictive modeling capabilities to...
- Grant Award Summary Icahn School of Medicine at Mount Sinai received a $633,750 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period August 1, 2025 through July 31, 2028. The award funds research investigating the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. This research contributes to the DHA's broader mission of transforming healthcare for...
- The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Icahn School of Medicine at Mount Sinai a $507,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2027. The award supports research to investigate tumor-intrinsic epigenetic mechanisms that modulate antitumor immune responses in metastatic prostate cancer. This research initiative advances the DHA's mission to transform healthcare...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $3.3M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Leveraging Personalized Stem Cell Therapy to Overcome Airway Reconstruction." The four-year award, which commenced June 1, 2025 and concludes May 31, 2029, supports advanced biomedical research aimed at developing innovative therapeutic...
- Federal Project Grant Award Summary Icahn School of Medicine at Mount Sinai received a $2.18M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to investigate metabolites and metabolic pathways associated with Crohn disease risk. The award, dated June 1, 2025, supports a four-year research initiative extending through June 30, 2029, conducted at the institution's New York campus. This biomedical research project aligns...
- The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
- Federal Grant Award Summary Icahn School of Medicine at Mount Sinai received a $695,546 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025 through September 30, 2027. The award supports research on central nervous system (CNS)-targeted antisense therapeutics for Powassan virus infection, conducted at the institution's New York, NY facility. This project aligns with the DHA's mission to develop...